Follow
Johannes Fahrmann
Title
Cited by
Cited by
Year
JAK/STAT3-regulated fatty acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance
T Wang, JF Fahrmann, H Lee, YJ Li, SC Tripathi, C Yue, C Zhang, ...
Cell metabolism 27 (1), 136-150. e5, 2018
6672018
Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells
WY Lam, AM Becker, KM Kennerly, R Wong, JD Curtis, EM Llufrio, ...
Immunity 45 (1), 60-73, 2016
2412016
Rise of deep learning for genomic, proteomic, and metabolomic data integration in precision medicine
D Grapov, J Fahrmann, K Wanichthanarak, S Khoomrung
Omics: a journal of integrative biology 22 (10), 630-636, 2018
2072018
Mass spectral feature list optimizer (MS-FLO): a tool to minimize false positive peak reports in untargeted liquid chromatography–mass spectroscopy (LC-MS) data processing
BC DeFelice, SS Mehta, S Samra, T Cajka, B Wancewicz, JF Fahrmann, ...
Analytical chemistry 89 (6), 3250-3255, 2017
1622017
Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance
A Mukherjee, CY Chiang, HA Daifotis, KM Nieman, JF Fahrmann, ...
Cancer research 80 (8), 1748-1761, 2020
1602020
Genomic, proteomic, and metabolomic data integration strategies
K Wanichthanarak, JF Fahrmann, D Grapov
Biomarker insights 10, BMI. S29511, 2015
1542015
Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study
DB Liesenfeld, D Grapov, JF Fahrmann, M Salou, D Scherer, R Toth, ...
The American journal of clinical nutrition 102 (2), 433-443, 2015
1412015
A plasma-derived protein-metabolite multiplexed panel for early-stage pancreatic cancer
JF Fahrmann, LE Bantis, M Capello, G Scelo, JB Dennison, N Patel, ...
JNCI: Journal of the National Cancer Institute 111 (4), 372-379, 2019
1052019
Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection
JF Fahrmann, CM Schmidt, X Mao, E Irajizad, M Loftus, J Zhang, N Patel, ...
Gastroenterology 160 (4), 1373-1383. e6, 2021
1042021
MCAM mediates chemoresistance in small-cell lung cancer via the PI3K/AKT/SOX2 signaling pathway
SC Tripathi, JF Fahrmann, M Celiktas, M Aguilar, KD Marini, MK Jolly, ...
Cancer Research 77 (16), 4414-4425, 2017
1032017
Deep metabolome: Applications of deep learning in metabolomics
Y Pomyen, K Wanichthanarak, P Poungsombat, J Fahrmann, D Grapov, ...
Computational and Structural Biotechnology Journal 18, 2818-2825, 2020
992020
Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma
WR Wikoff, D Grapov, JF Fahrmann, B DeFelice, WN Rom, HI Pass, K Kim, ...
Cancer prevention research 8 (5), 410-418, 2015
902015
Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma
M Çeliktaş, I Tanaka, S Chandra Tripathi, JF Fahrmann, ...
Journal of the National Cancer Institute 109 (3), djw231, 2017
802017
An in silico MS/MS library for automatic annotation of novel FAHFA lipids
Y Ma, T Kind, A Vaniya, I Gennity, JF Fahrmann, O Fiehn
Journal of cheminformatics 7, 1-5, 2015
802015
Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma
J Vykoukal, N Sun, C Aguilar-Bonavides, H Katayama, I Tanaka, ...
Oncotarget 8 (56), 95466, 2017
742017
Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice
P Deol, J Fahrmann, J Yang, JR Evans, A Rizo, D Grapov, M Salemi, ...
Scientific reports 7 (1), 12488, 2017
722017
Integrated metabolomics and proteomics highlight altered nicotinamide and polyamine pathways in lung adenocarcinoma
JF Fahrmann, D Grapov, K Wanichthanarak, BC DeFelice, MR Salemi, ...
Carcinogenesis 38 (3), 271-280, 2017
672017
Metabolic changes associated with methionine stress sensitivity in MDA-MB-468 breast cancer cells
SL Borrego, J Fahrmann, R Datta, C Stringari, D Grapov, M Zeller, Y Chen, ...
Cancer & metabolism 4, 1-17, 2016
662016
Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer
JF Fahrmann, K Kim, BC DeFelice, SL Taylor, DR Gandara, KY Yoneda, ...
Cancer epidemiology, biomarkers & prevention 24 (11), 1716-1723, 2015
662015
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer
J Vykoukal, JF Fahrmann, JR Gregg, Z Tang, S Basourakos, E Irajizad, ...
Nature communications 11 (1), 4279, 2020
642020
The system can't perform the operation now. Try again later.
Articles 1–20